Exclusive patent and know-how license to make, have made, use, sell, and sublicense pharmaceutical products using MMP Inhibitor compounds for topical medical and cosmetic uses, including treatment of chemical burns and injuries, treatment of skin deterioration, and treatment of other dermatological wounds, diseases and conditions such as chronic wounds or psoriasis.

Other literature type . 2001

Data sources: Datacite

descriptionPublicationkeyboard_double_arrow_right Other literature type 01 Jan 2001Publisher:RoyaltyStat

Authors: RoyaltyStat;

No summary information available

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

0

Average

Upload OA version

Are you the author of this publication? Upload your Open Access version to Zenodo!

It’s fast and easy, just two clicks!